medication adherence app

A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not.

Replacing the frequent home visits often necessary for tuberculosis treatment with video visits facilitated by an app appears to be a cost-effective, well-received means of ensuring adherence throughout therapy, according to a recently published pilot study.

A study published in JAMA Internal Medicine today demonstrated that a smartphone app could lead to small improvements in self-reported medication adherence among participants with poorly controlled hypertension.

Vancouver-based Ayogo has raised $2.

Cincinnati, Ohio-based MedaCheck, a company that sells a dedicated medication reminder tablet for seniors, has raised $1.

Medication adherence app company MediSafe raised $6 million in a round led by Pitango Venture Capital with participation from 7wire Ventures as well as existing investors lool Ventures, TriVentures, and Eyal Gura.